- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00993902
Double and Single Intrauterine Insemination In Controlled Ovarian Stimulation (COH) Cycles With Multifollicular Development
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Metaanalysis for the effects of double IUI demonstrates that effects of this procedure is not different from single IUI. It is known that nearly 25% of coh cycles is evident by monofollicular development.For this reason it is possible that this monofollicular cycles in the studies could decrease the effects of double IUI.
Inclusion criteria:
- Patients with unexplained infertility or mild male factor infertility whom admitted to the COH+IUI programme in our infertility unit.
- Female age <37 years old.
- Baseline FSH <12 mIU/L
- Total antral follicle count>6
- During the first three cycles of COH+IUI
- Minimum 2 follicles >16 mm at the day of HCG.
Primary outcome:
Ongoing pregnancy rates
Secondary outcomes:
The effects of different coh regimens (CC,FSH,CC+FSH)on the outcomes.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Adana, Turkey, 01120
- Baskent University Medical Faculty Obstetric and Gynecelogy Department, Infertility and IVF unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Unexplained and mild male factor infertile patients
- Minimum 2 follicles >16 mm at the day of HCG
- First 3 cycles
Exclusion Criteria:
- Basal FSH >12 mIU/L
- Total antral follicle count<6
- Severe male factor infertility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Single IUI
Single IUI will be carried on after 36-38 hours of HCG administration
|
Single IUI after 36-38 hours of HCG
Other Names:
|
|
Active Comparator: Double IUI
|
Double insemination after 18 and 40 hours of HCG administration.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ongoing pregnancy rates
Time Frame: pregnancy >12 weeks of gestation
|
pregnancy >12 weeks of gestation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The effects of different coh regimens on outcomes
Time Frame: 14 days after IUI procedure
|
14 days after IUI procedure
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BU1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Medipol UniversityNot yet recruitingMale Infertility | Unexplained Infertility | Sperm DNA Fragmentation
Clinical Trials on Intrauterine insemination (single)
-
HaEmek Medical Center, IsraelTerminated
-
Universitas PadjadjaranCompleted
-
Pamukkale UniversityCompleted
-
CHU de Quebec-Universite LavalRecruiting
-
IVI BilbaoCompletedEndometriosis I-II
-
Institut Universitari DexeusCompletedInfertility | Infertility, Male | Same-Sex Marriage | Parent, Single
-
HaEmek Medical Center, IsraelCompleted
-
Mansoura UniversityCompletedInfertility | Polycystic Ovarian Syndrome | Intrauterine InseminationEgypt
-
Medical University of ViennaReproductive Sciences Ltd.UnknownInseminationAustria, France, Germany, United Kingdom
-
Jose Antonio MorenoUniversitat Autonoma de BarcelonaCompletedInfertility, Female | Anti-Mullerian Hormone DeficiencySpain